Related Experiment Video

Updated: Jun 8, 2026

Near Infrared Optical Projection Tomography for Assessments of β-cell Mass Distribution in Diabetes Research
15:18

Near Infrared Optical Projection Tomography for Assessments of β-cell Mass Distribution in Diabetes Research

Published on: January 12, 2013

17.0K

Latest Innovations in Biochemical and Imaging Diagnostics in Endocrinology

Anat Ben-Shlomo1, Maria Fleseriu2

  • 1Pituitary Center, Division of Endocrinology, Diabetes, & Metabolism, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

Endocrinology and Metabolism Clinics of North America
|August 2, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.2K
Live-Cell Förster Resonance Energy Transfer Imaging of Metabolically Regulated Akt Activation Dynamics in HepG2 Cells
08:03

Live-Cell Förster Resonance Energy Transfer Imaging of Metabolically Regulated Akt Activation Dynamics in HepG2 Cells

Published on: May 23, 2025

826

Related Experiment Videos

Last Updated: Jun 8, 2026

Near Infrared Optical Projection Tomography for Assessments of β-cell Mass Distribution in Diabetes Research
15:18

Near Infrared Optical Projection Tomography for Assessments of β-cell Mass Distribution in Diabetes Research

Published on: January 12, 2013

17.0K
An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

11.2K
Live-Cell Förster Resonance Energy Transfer Imaging of Metabolically Regulated Akt Activation Dynamics in HepG2 Cells
08:03

Live-Cell Förster Resonance Energy Transfer Imaging of Metabolically Regulated Akt Activation Dynamics in HepG2 Cells

Published on: May 23, 2025

826

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.

Articles linked to this work by shared authors, journal, and citation graph.

Genetic testing in pituitary adenomas: a Pituitary Society International Consensus Statement.

Nature reviews. Endocrinology·2026

Functioning pituitary adenomas in pregnancy: updates and controversies.

Current opinion in endocrinology, diabetes, and obesity·2026

Depression and anxiety in patients with endogenous Cushing syndrome: a nationwide matched-cohort study using affective drug dispensations.

European journal of endocrinology·2026

Consensus on Biomarker Utility for ACTH-Dependent Cushing's Syndrome: A Pituitary Society Modified Delphi Panel.

The Journal of clinical endocrinology and metabolism·2026

Risk of infection-related hospitalization is more than doubled in Cushing's syndrome vs matched controls.

The American journal of medicine·2026

GLP-1 Receptor Agonist Exposure and Malignancy Risk in Patients With Endogenous Cushing's Syndrome.

The Journal of clinical endocrinology and metabolism·2026

The Horizon Ahead: Emerging Adjunctive Therapies for Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026

Expectations and Experiences: What People with Type 1 Diabetes Really Want from Adjunctive Therapies.

Endocrinology and metabolism clinics of North America·2026

Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents.

Endocrinology and metabolism clinics of North America·2026

Clinical Guidance on the Safe Use of Sodium-Glucose Cotransporter Inhibitors in Adults with Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026

Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026

Future of Continuous Ketone Monitoring and Its Utility for Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes.

Endocrinology and metabolism clinics of North America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us